John Leite

John Leite, Ph.D., is Senior Vice President, General Manager, Pulmonology & Market Access at Veracyte. In this role, Dr. Leite leads all aspects – including market development, product marketing, reimbursement, sales and lab operations – of Veracyte’s diagnostic tests in thyroid cancer and pulmonology.

Dr. Leite joined Veracyte in September 2022, bringing with him deep diagnostics industry leadership experience. Previously, he served as Chief Business Officer for InterVenn Biosciences, a private-stage diagnostics company, where he was responsible for the company’s commercial, partnership and market access strategy. Prior to that he held leadership positions at Illumina from 2014 to 2020, where he initially served as Vice President, Oncology, Market Development and Product Development, and then as Vice President, Clinical Business Development. Prior to Illumina, he was Vice President of Commercial Strategy and Market Access at Genoptix Medical Laboratories.

Dr. Leite holds a B.S. in Biochemistry from Rutgers University and a Ph.D. in Biochemistry and Molecular Genetics from the University of Pittsburgh School of Medicine. In addition, he completed post-doctoral work as a National Research Service Award Fellow at the California Institute of Technology.